Human Genome Epidemiology Literature Finder
|
Records 1 - 29 (of 29 Records) |
| Query Trace: Disease Progression and ASXL1[original query] |
|---|
| Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes. Haematologica 2013 Dec 98 (12): 1856-64. Fernandez-Mercado Marta, Burns Adam, Pellagatti Andrea, Giagounidis Aristoteles, Germing Ulrich, Agirre Xabier, Prosper Felipe, Aul Carlo, Killick Sally, Wainscoat James S, Schuh Anna, Boultwood Jacqueli |
| Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression. American journal of hematology 2014 Feb 89 (2): 181-6. Hou Hsin-An, Kuo Yuan-Yeh, Tang Jih-Luh, Chou Wen-Chien, Yao Ming, Lai Yan-Jun, Lin Chien-Chin, Chen Chien-Yuan, Liu Chieh-Yu, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. American journal of hematology 2014 Feb 89 (2): 137-44. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Chen Chien-Yuan, Lai Yan-Jun, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution. American journal of hematology 2014 Aug 89 (8): E109-15. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Wu Shang-Ju, Liu Chieh-Yu, Chen Chien-Yuan, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Hsu Szu-Chun, Ko Bor-Sheng, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
| Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget 2016 Jan . Hou Hsin-An, Liu Chieh-Yu, Kuo Yuan-Yeh, Chou Wen-Chien, Tsai Cheng-Hong, Lin Chien-Chin, Lin Liang-In, Tseng Mei-Hsuan, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Chen Chien-Yuan, Lin Chien-Ting, Wu Shang-Ju, Tsay Woei, Tien Hwei-Fa |
| Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease. Leukemia research 2017 Jun 60 18-23. Barosi Giovanni, Massa Margherita, Campanelli Rita, Fois Gabriela, Catarsi Paolo, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bosoni Tiziana, Magrini Umberto, Gale Robert P, Rosti Vittor |
| Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 1 25 (6): 1142-1151. Tamari Roni, Rapaport Franck, Zhang Nan, McNamara Caroline, Kuykendall Andrew, Sallman David A, Komrokji Rami, Arruda Andrea, Najfeld Vesna, Sandy Lonette, Medina Juan, Litvin Rivka, Famulare Christopher A, Patel Minal A, Maloy Molly, Castro-Malaspina Hugo, Giralt Sergio A, Weinberg Rona S, Mascarenhas John O, Mesa Ruben, Rondelli Damiano, Dueck Amylou C, Levine Ross L, Gupta Vikas, Hoffman Ronald, Rampal Raajit |
| Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor. OncoTargets and therapy 2020 9 13 8581-8591. Wu Waner, Xu Na, Zhou Xuan, Liu Liang, Tan Yaxian, Luo Jie, Huang Jixian, Qin Jiayue, Wang Juan, Li Zhimin, Yin Changxin, Zhou Lingling, Liu Xiao |
| Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome. Best practice & research. Clinical haematology 2020 5 33 (2): 101171. Lasho Terra, Patnaik Mrinal |
| ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients. British journal of haematology 2020 Feb . Andréasson Björn, Pettersson Helna, Wasslavik Carina, Johansson Peter, Palmqvist Lars, Asp Jul |
| Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
| ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome. Blood advances 2021 9 6 (3): 793-807. West Robert R, Calvo Katherine R, Embree Lisa J, Wang Weixin, Tuschong Laura M, Bauer Thomas R, Tillo Desiree, Lack Justin, Droll Stephenie, Hsu Amy P, Holland Steven M, Hickstein Dennis |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. Clinical lymphoma, myeloma & leukemia 2021 11 22 (5): e293-e299. Polprasert Chantana, Niparuck Pimjai, Rattanathammethee Thanawat, Chuncharunee Suporn, Kobbuaklee Sirorat, Songserm Kritanan, Suksusut Amornchai, Trithiphen Sasinipa, Lanamtieng Theerin, Kongkiatkamon Sunisa, Chanswangphuwana Chantiya, Lawasut Panisinee, Bunworasate Udomsak, Rojnuckarin Ponlap |
| Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies. Cancers 2021 11 13 (22): . Brune Magdalena M, Rau Achim, Overkamp Mathis, Flaadt Tim, Bonzheim Irina, Schürch Christian M, Federmann Birgit, Dirnhofer Stefan, Fend Falko, Tzankov Alexand |
| Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis. Theranostics 2021 1 11 (1): 292-303. Kluin-Nelemans Hanneke C, Jawhar Mohamad, Reiter Andreas, van Anrooij Bjorn, Gotlib Jason, Hartmann Karin, Illerhaus Anja, Oude Elberink Hanneke N G, Gorska Aleksandra, Niedoszytko Marek, Lange Magdalena, Scaffidi Luigi, Zanotti Roberta, Bonadonna Patrizia, Perkins Cecelia, Elena Chiara, Malcovati Luca, Shoumariyeh Khalid, von Bubnoff Nikolas, Müller Sabine, Triggiani Massimo, Parente Roberta, Schwaab Juliana, Kundi Michael, Fortina Anna Belloni, Caroppo Francesca, Brockow Knut, Zink Alexander, Fuchs David, Angelova-Fischer Irena, Yavuz Akif Selim, Doubek Michael, Mattsson Mattias, Hagglund Hans, Panse Jens, Simonowski Anne, Sabato Vito, Schug Tanja, Jentzsch Madlen, Breynaert Christine, Várkonyi Judit, Kennedy Vanessa, Hermine Olivier, Rossignol Julien, Arock Michel, Valent Peter, Sperr Wolfgang |
| The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis. Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 902-908. Pan Yuxia, Wang Xingzhe, Wen Shupeng, Liu Xiaojun, Yang Lin, Luo Jianm |
| Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis. Cancers 2022 5 14 (10): . González-López Oscar, Muñoz-González Javier I, Orfao Alberto, Álvarez-Twose Iván, García-Montero Andrés |
| Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current oncology (Toronto, Ont.) 2022 2 29 (2): 805-815. Adam Franziska C, Szybinski Jakub, Halter Jörg P, Cantoni Nathan, Wenzel Friedel, Leonards Katharina, Brkic Sime, Passweg Jakob R, Touw Ivo, Maxson Julia E, Meyer Sara |
| BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
| Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR?ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study. Cancers 2022 12 14 (23): . Hu Shiwei, Chen Dan, Xu Xiaofei, Zhang Lan, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Jin Jie, Huang Ji |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
| Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
| Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study. The Lancet. Haematology 2023 12 11 (1): e51-e61. Catherine Cargo, Elsa Bernard, Tumas Beinortas, Kelly L Bolton, Paul Glover, Helen Warren, Daniel Payne, Rukhsaar Ali, Alesia Khan, Mike Short, Suzan Van Hoppe, Alex Smith, Jan Taylor, Paul Evans, Elli Papaemmanuil, Simon Crou |
| [Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model]. Zhonghua yi xue za zhi 2024 7 104 (25): 2336-2341. J Y Ma, Y H Zhang, G S Teng, C X Du, H Q Zhang, Y Wang, Y Q Li, Y F Duan, Y Zhou, Z H Shao, J B |
| [Diagnosis and Risk Stratification of Acute Myeloid Leukemia, Myelodysplasia -Related]. Zhongguo shi yan xue ye xue za zhi 2024 10 32 (5): 1372-1376. Hui Yang, Rui Guo, Yu Shi, Chun Qiao, Yan Wang, Yu-Jie Wu, Hai-Rong Q |
| Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Annals of hematology 2024 1 . Marta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes, Alberto Alvarez-Larr |
- Page last reviewed:Feb 1, 2024
- Content source: